Curanex Pharmaceuticals Inc Common Stock (CURX)
CURX Stock Price Chart
Explore Curanex Pharmaceuticals Inc Common Stock interactive price chart. Choose custom timeframes to analyze CURX price movements and trends.
CURX Company Profile
Discover essential business fundamentals and corporate details for Curanex Pharmaceuticals Inc Common Stock (CURX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Aug 2025
Employees
6.00
Website
https://www.curanexpharma.comCEO
Jun Liu
Description
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
CURX Financial Timeline
Browse a chronological timeline of Curanex Pharmaceuticals Inc Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 May 2026
EPS came in at -$0.11 .
Earnings released on 30 Mar 2026
EPS came in at -$0.12 .
Earnings released on 14 Nov 2025
EPS came in at -$0.04 .
CURX Stock Performance
Access detailed CURX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
